MAP1LC3A and central nervous system cancer: The expression of MAP1LC3A was reported to be suppressed in many tumor cell lines, suggesting that it may be involved in the carcinogenesis of multiple tumors, such as gastric cancer, esophageal squamous carcinoma, osteosarcoma, and glioma [34, 35].